TL;DR
Get self-care and calm essentials delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
In a first-person report published by Being Patient on October 6, 2026, Ron Carr describes three health notifications that changed how he understood Alzheimer’s and cardiovascular risk. His account distinguishes an APOE4 genetic risk result from a coronary artery disease diagnosis; the supplied report excerpt does not identify the third notification.
Ron Carr, a retired local government executive and patient advocate, says an APOE4 genetic result and a coronary artery calcium scan changed how he thought about Alzheimer’s and heart disease. In a first-person report published by Being Patient on October 6, 2026, Carr describes the first two of three health notifications; the supplied article excerpt does not include the third, leaving that part of the headline’s premise unconfirmed here.
Carr writes that a genetic test, taken about two years before his account, showed he carries two copies of APOE4. He describes feeling that the result had rewritten his future and says ordinary lapses, such as forgetting a name or misplacing keys, began to feel like signs of illness. He then immersed himself in Alzheimer’s research and repeatedly changed his diet, exercise routine and supplement use.
Over time, Carr says he came to understand that APOE4 is a risk factor, not an Alzheimer’s diagnosis, and that genes may protect against APOE4 Alzheimer’s risk. He cites the Lancet Commission estimate that up to 45% of dementia cases may be attributable to potentially modifiable risk factors. That figure is an estimate about dementia at a population level, not a prediction of Carr’s individual risk or proof that any one intervention will prevent disease.
The second notification came after a clinician at the University of Southern California’s Center for Personalized Brain Health discussed APOE4’s role in lipid transport and Carr underwent a coronary artery calcium scan. At age 65, he says, the scan showed significant calcified plaque, concentrated largely in the left anterior descending artery. Carr reports that clinicians then lowered his LDL cholesterol and ApoB targets and that follow-up testing found no evidence of structural heart damage.
How Risk Results Changed Carr’s Care
Carr’s account highlights the difference between a genetic risk marker and an identified disease. He says the APOE4 result prompted anxiety and an intensive search for ways to change his future, while the scan revealed coronary plaque despite his feeling healthy. The two notifications led to different responses: learning about dementia risk and changing health habits, then discussing treatment after an imaging finding.
The story also shows why test results need clinical interpretation. A genetic result cannot establish that someone has Alzheimer’s, and a personal narrative cannot show that Carr’s dietary changes, supplements or other actions will prevent dementia. His report describes his experience; it is not evidence that the same tests or choices are appropriate for everyone. Readers considering genetic testing or cardiovascular screening should discuss potential benefits and limits with a qualified health professional.
genetic testing kit for Alzheimer's risk
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
From APOE4 Testing to Heart Imaging
Carr identifies himself as a patient advocate focused on Alzheimer’s prevention, genetic testing and cardiovascular health. He says he has shared his perspective through the USC Center for Personalized Brain Health and the Family Heart Foundation, where he serves as an ambassador. His account is therefore first-person reporting, not a clinical study or a medical guideline.
He also describes a family history that shaped his concerns: his father had a heart attack at 65. Carr says he had run long distances, followed a heart-conscious diet and eventually took statins, but the calcium scan still showed plaque. The excerpt says his clinician subsequently intensified treatment; it does not provide his scan score, medication names or later cholesterol values.
“APOE4 is not a diagnosis. It is a risk factor.”
— Ron Carr, describing his APOE4 result
The Third Notification Is Missing
The source material supplied for this article stops during Carr’s discussion of the second notification. Although the headline refers to three health notifications, the excerpt does not state what the third was or what it showed. It would be inaccurate to infer that detail.
The excerpt also does not provide the calcium score, the full treatment plan, the timing or results of subsequent tests, or evidence connecting Carr’s individual health decisions to a change in his Alzheimer’s risk. The 45% figure is attributed to the Lancet Commission’s estimate for potentially modifiable factors across dementia cases; the supplied text does not set out its methods or individual applicability.
More of Carr’s Account Needed
The next step for understanding the three-notification story is access to the remainder of Carr’s report, which may explain the third result and how he responded. Until that information is available, only the APOE4 finding and coronary scan described in the supplied excerpt can be reported.
For readers, the account underscores the value of asking clinicians what a test can and cannot establish, what follow-up is warranted, and how personal and family history affect interpretation. Any broader conclusions about Alzheimer’s prevention require evidence beyond one person’s experience.
Key Questions
What did Carr learn from his genetic test?
He says the test found two copies of APOE4, a genetic risk factor associated with late-onset Alzheimer’s disease. He emphasizes that this result is not itself an Alzheimer’s diagnosis.
What did the coronary calcium scan show?
Carr reports significant calcified plaque in his coronary arteries, with almost all of it concentrated in the left anterior descending artery. The supplied excerpt does not give a calcium score.
What was the third health notification?
The source excerpt provided here does not identify the third notification. The headline refers to three, but only the genetic result and heart scan are described in the available text.
Does carrying APOE4 mean someone will develop Alzheimer’s?
No. Carr describes APOE4 as a risk factor, not a diagnosis. The excerpt does not provide an individual probability of developing the disease; people with questions about genetic testing should consult a qualified health professional.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
